B. Lynne Parshall - Jul 29, 2024 Form 4 Insider Report for CYTOKINETICS INC (CYTK)

Role
Director
Signature
/s/ John O. Faurescu, attorney-in-fact for Ms. Parshall
Stock symbol
CYTK
Transactions as of
Jul 29, 2024
Transactions value $
-$191,150
Form type
4
Date filed
7/31/2024, 04:39 PM
Previous filing
Jul 17, 2024
Next filing
Aug 12, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CYTK Common Stock Options Exercise $108K +5K +24.27% $21.61 25.6K Jul 29, 2024 Direct
transaction CYTK Common Stock Sale -$299K -5K -19.53% $59.84 20.6K Jul 29, 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CYTK Non-Qualified Stock Option (Right to Buy) Options Exercise $0 -5K -25% $0.00 15K Jul 29, 2024 Common Stock 5K $21.61 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Options shall vest and become exercisable in 12 equal monthly installments as from the date of the grant.